Summary
Bobbie Pharmaceutical Services is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €17.51M and a net result of €-1.15M. Its solvency ranks better than 30% of 2394 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Model not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit advice for your own amount and term
Signals
Two signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Growing equity
Reported equity is higher than in 2024 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
242425
2024 to 2025 · latest year €17.51M
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
28 d early
2024
8 d early
2024
35 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Equity
€17.51M▲ 79.2%
2024 · €9.77M
2024: €8.15M
2024: €9.77M
2024 → 2025
Net result
€-1.15M
2024 · €1.61M
2024: €2.90M
2024: €1.61M
2024 → 2025
Total assets
€46.96M▲ 40.9%
2024 · €33.33M
2024: €34.09M
2024: €33.33M
2024 → 2025
Solvency
37.3%▲ 8.0pp
2024 · 29.3%
2024: 23.9%
2024: 29.3%
2024 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202420242025Trend
Turnover€1.95M€1.53M▼ 21.8%
Equity€8.15M-€9.77M▲ 19.8%€17.51M▲ 79.2%
Operating result€998k-€1.66M▲ 66.2%€74k▼ 95.5%
Net result€2.90M-€1.61M▼ 44.5%€-1.15M
Result per fiscal year
Operating resultNet result
Multiple fiscal year ends fall in the same calendar year; an annual trend is not displayed.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €46.96M
Fixed assets
€45.24M ▲ 39.2%
Current assets
€1.73M ▲ 109%
Equity and liabilities €46.96M
Equity
€17.51M ▲ 79.2%
Debt
€29.46M ▲ 25.0%
Debt's share of the balance-sheet total falls from 70.7% to 62.7%. Equity and debt are higher.
Key figures and ratios
ROE
-6.6%▼
2024 · 16.5%
ROA
-2.5%▼
2024 · 4.8%
Debt ≤ 1 year
€9.27M▲
2024 · €5.11M
Debt > 1 year
€19.69M▲
2024 · €18.12M
Income taxes
€0▼
2024 · €227k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 66 lines
Balance sheet
Code20242025
Assets
Total assets20/58€33.33M€46.96M▲
Fixed assets21/28€32.50M€45.24M▲
Intangible fixed assets21€69k€571k▲
Tangible fixed assets22/27-€10k
Plant, machinery and equipment23-€10k
Financial fixed assets28€32.43M€44.66M▲
Affiliated companies280/1€32.43M€44.65M▲
Participating interests280€32.43M€44.65M▲
Other financial fixed assets284/8-€570
Amounts receivable and cash guarantees285/8-€570
Current assets29/58€827k€1.73M▲
Stocks and contracts in progress3€0€0=
Amounts receivable within one year40/41€744k€1.64M▲
Trade receivables40€495k€1.23M▲
Other amounts receivable41€248k€415k▲
Cash at bank and in hand54/58€83k€80k▼
Deferred charges and accrued income490/1-€4k
Equity and liabilities
Total equity and liabilities10/49€33.33M€46.96M▲
Equity10/15€9.77M€17.51M▲
Contributions10/11€5.25M€13.79M▲
Reserves13€4.52M€3.71M▼
Distributable reserves133€4.52M€3.71M▼
Amounts payable17/49€23.56M€29.46M▲
Amounts payable after more than one year17€18.12M€19.69M▲
Financial debts170/4€18.12M€19.69M▲
Credit institutions173€9.37M€11.89M▲
Other loans174€8.75M€7.80M▼
Amounts payable within one year42/48€5.11M€9.27M▲
Current portion of amounts payable after more than one year42€874k€1.28M▲
Financial debts43€3.60M€3.61M▲
Credit institutions430/8€3.60M€3.61M▲
Trade debts44€80k€643k▲
Suppliers440/4€80k€643k▲
Taxes, remuneration and social security45€359k€227k▼
Taxes450/3€359k€227k▼
Other amounts payable47/48€200k€3.51M▲
Accrued charges and deferred income492/3€330k€505k▲
Income statement
Code20242025
Operating income70/76A€1.95M€1.74M▼
Turnover70€1.95M€1.53M▼
Own construction capitalised72-€214k
Operating charges60/66A€296k€1.67M▲
Goods for resale, raw materials and consumables60€111k€0▼
Purchases600/8€111k€0▼
Services and other goods61€161k€1.58M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€23k€88k▲
Other operating charges640/8€718€1k▲
Operating profit (loss)9901€1.66M€74k▼
Financial income75/76B€1.00M€846▼
Recurring financial income75€1.00M€846▼
Income from financial fixed assets750€1.00M€0▼
Income from current assets751-€846
Other financial income752/9€0€0▲
Financial charges65/66B€819k€1.23M▲
Recurring financial charges65€819k€1.23M▲
Debt charges650€817k€1.20M▲
Other financial charges652/9€1k€27k▲
Profit (loss) for the period before taxes9903€1.84M€-1.15M▼
Income taxes67/77€227k€0▼
Taxes670/3€227k€0▼
Profit (loss) for the period9904€1.61M€-1.15M▼
Profit (loss) for the period to be appropriated9905€1.61M€-1.15M▼
Appropriation of the result
Profit (loss) to be appropriated9906€1.61M€-1.15M▼
Transfer from equity791/2-€1.15M
From reserves792-€1.15M
Transfer to equity691/2€1.61M€0▼
To other reserves6921€1.61M€0▼
The notes to these accounts (55 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
12-02
State Gazette act
General meeting · Merger
Dissolution · Capital
12-02
State Gazette act
General meeting · Merger
Dissolution · Capital · Thomas Dusselier
2025
31-12
Financial
Weakest financial yearnet €-1.15M ▼171%
Net result drops to €-1.15M, the lowest in the series.
31-12
Financial
Equity above €10MEq €17.51M ▲79.2%
Equity rises from €9.77M to €17.51M.
23-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
26-09
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wingene · 1 establishment unit since 2023
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Flandria 38750 WingeneGround area
1,648 m²
Building footprint
866 m²
Volume, LiDAR
251 m³
Parcel 37019B1104/00A000, Flanders · tallest building 5.4 m. Linked by address, not a title deed.
1 establishment unit
Bobbie Pharmaceutical Services
since 20232.348.456.310
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 37019B1104/00A000 | Flanders | 1,648 m² | 1 · 866 m² | 5.4 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
699400NIDL1FTULYG509
Similar companies · same sector, comparable size
B-MAX HOLDING
BE 0894.503.514
Antwerpen · Eq €17.50M
DDG INVEST
BE 0832.383.229
Sint-Martens-Latem · Eq €17.54M
OMICON
BE 0832.354.822
Knokke-Heist · Eq €17.47M
Larpino
BE 0832.705.012
Antwerpen · Eq €17.56M
REYNESCO
BE 0436.326.982
Boechout · Eq €17.43M
Of 24,725 companies in sector 64210 we hold annual accounts for 19,762. 4,580 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded09-03-2023
Fiscal year end31-12
Abbreviation NL
BOPHAS
Activities, NACEBEL 2025
64210Activities of holding companies
62200Computer consultancy and computer facilities management
70100Activities of head offices
70200Business and other management consultancy
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.